Ghanaian President Mahama recently explained at the Council on Foreign Relations that his Cabinet rejected a proposed US health compact worth $109 million over five years. The compact required Ghana to hand over its pathogen profile and medical records, and would have barred the Food and Drugs Authority from inspecting imported medical products. Mahama described the terms as "humiliating" and stated that Cabinet quickly rejected the compact.
The US Embassy in Accra responded that it had sought only aggregate data without personal identifiers, similar to the President's Emergency Plan for AIDS Relief (PEPFAR). The Embassy also stated that the US had invested $2.2 billion in Ghana's health sector since 2012 and left the door open for future negotiations. This public response signaled that the US's real audience was the Ghanaian public, not the government.
The negotiating text of the compact has not been published, leading to a factual dispute between the two sides. Confirmed claims include the pathogen profile, medical records, counterpart funding, and an exemption from FDA inspection. Reported claims include a 25-year data term on a five-year program and broad US discretion over the data. The central dispute revolves around whether "medical records" refers to patient files or aggregate indicators.
An intelligence analyst noted that the US Embassy's response was silent on several key issues, including the 25-year term, commercial use of the data, and the FDA exemption. This narrow denial suggests that Washington feels exposed on these points. The Embassy's comparison of specimen sharing to cooperation against Ebola is an argument for guaranteed benefit-sharing, which is precisely what is in dispute.
Many Ghanaians suspect a hidden agenda or conspiracy behind the compact, but there is likely none. Instead, the issue appears to be a transactional bargain where health data and biological material are being bought. The bargain has three layers: outbreak detection and accountability to Congress, aid as leverage, and access without obligation.
The compact would have added informational, biological, and regulatory access to Ghana, each less visible and harder to undo. Ghana granted operational access through joint military medical exercises and territorial access through the 2018 Defence Cooperation Agreement. A clear "NO" from Ghana sets a floor for other African states and strengthens Ghana's hand, but also makes quiet renegotiation harder.
The durable model for negotiations is firm in substance and measured in tone: refuse specific terms, publish the reasons, fund the alternative, and keep a counter-offer on the table. This approach shows the West that Ghana can manage without the money. Publishing the text of the compact can settle the dispute, but some reasons for secrecy are legitimate, such as negotiating drafts and Cabinet papers being confidential by convention.
Key points
- Ghana's President Mahama rejected a $109 million US health compact due to concerns over data sharing and sovereignty.
- The US Embassy responded that it had sought only aggregate data without personal identifiers.
- The negotiating text has not been published, leading to a factual dispute between the two sides.
